Senescence evasion by MCF-7 human breast tumor-initiating cells

IntroductionA subpopulation of cancer cells, tumor-initiating cells, is believed to be the driving force behind tumorigenesis and resistance to radiation and chemotherapy. The persistence of tumor-initiating cells may depend on altered regulation of DNA damage and checkpoint proteins, as well as a reduced propensity to undergo apoptosis or senescence.MethodsTo test this hypothesis, we isolated CD24-/low/CD44+ tumor-initiating cells (as mammospheres) from MCF-7 breast cancer cells grown in adherent monolayer culture, and carried out a comprehensive comparison of cell death and DNA damage response pathways prior to and after exposure to ionizing radiation in mammospheres and monolayer MCF-7 cells. Single and double-strand break repair was measured by single-cell gel electrophoresis. The latter was also examined by phosphorylation of histone H2AX and formation of 53BP1 and Rad51 foci. Apoptosis was quantified by flow-cytometric analysis of annexin V-binding and senescence was analyzed on the basis of cellular β-galactosidase activity. We employed the telomeric repeat amplification protocol to quantify telomerase activity. Expression of key DNA repair and cell cycle regulatory proteins was detected and quantified by western blot analysis.ResultsOur data demonstrate that in comparison to the bulk population of MCF-7 cells (predominantly CD24+/CD44+), the MCF-7 mammosphere cells benefit from a multifaceted approach to cellular protection relative to that seen in monolayer cells, including a reduced level of reactive oxygen species, a more active DNA single-strand break repair (SSBR) pathway, possibly due to a higher level of expression of the key SSBR protein, human AP endonuclease 1 (Ape1), and a significantly reduced propensity to undergo senescence as a result of increased telomerase activity and a low level of p21 protein expression. No significant difference was seen in the rates of double-strand break repair (DSBR) between the two cell types, but DSBR in mammospheres appears to by-pass the need for H2AX phosphorylation.ConclusionsEnhanced survival of MCF-7 tumor-initiating cells in response to ionizing radiation is primarily dependent on an inherent down-regulation of the senescence pathway. Since MCF-7 cells are representative of cancer cells that do not readily undergo apoptosis, consideration of senescence pathways may play a role in targeting stem cells from such tumors.

[1]  J. Lunec,et al.  The role of the tumour suppressor p33ING1b in human neoplasia , 2003, Journal of clinical pathology.

[2]  L. Mullenders,et al.  The role of nucleotide excision repair in protecting embryonic stem cells from genotoxic effects of UV-induced DNA damage. , 1999, Nucleic acids research.

[3]  M. Vivanco,et al.  Growth and differentiation of progenitor/stem cells derived from the human mammary gland. , 2004, Experimental cell research.

[4]  Arthur N. L. Chiu,et al.  Hypersensitivity to chromium-induced DNA damage correlates with constitutive deregulation of upstream p53 kinases in p21-/- HCT116 colon cancer cells. , 2008, DNA repair.

[5]  Junjie Chen,et al.  Cellular senescence and DNA repair. , 2006, Experimental cell research.

[6]  A. Collins,et al.  The comet assay for DNA damage and repair , 2004, Molecular biotechnology.

[7]  David J. Chen,et al.  DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells. , 2006, DNA repair.

[8]  S. Srivastava,et al.  Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells , 1998, Oncogene.

[9]  S. Narod,et al.  Towards a dietary prevention of hereditary breast cancer. , 2005, Cancer causes & control : CCC.

[10]  Charlotte Kuperwasser,et al.  Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy , 2008, Breast Cancer Research.

[11]  P. Baumann,et al.  Role of the human RAD51 protein in homologous recombination and double-stranded-break repair. , 1998, Trends in biochemical sciences.

[12]  J. Hoeijmakers.  Genome maintenance mechanisms for preventing cancer , 2001, Nature.

[13]  I. H. Engels,et al.  Apoptosis Resistance of MCF-7 Breast Carcinoma Cells to Ionizing Radiation Is Independent of p53 and Cell Cycle Control but Caused by the Lack of Caspase-3 and a Caffeine-Inhibitable Event , 2004, Cancer Research.

[14]  R. Eils,et al.  Distinct molecular phenotype of malignant CD34+ hematopoietic stem and progenitor cells in chronic myelogenous leukemia , 2005, Oncogene.

[15]  P. Calsou,et al.  Involvement of Poly(ADP-ribose) Polymerase-1 and XRCC1/DNA Ligase III in an Alternative Route for DNA Double-strand Breaks Rejoining* , 2004, Journal of Biological Chemistry.

[16]  J. Rich,et al.  Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  M. Daidone,et al.  Breast cancer stem cells: an overview. , 2006, European journal of cancer.

[18]  J. Stringer,et al.  Embryonic stem cells and somatic cells differ in mutation frequency and type , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Narod,et al.  Brief Report: Towards a dietary prevention of hereditary breast cancer , 2005, Cancer Causes & Control.

[20]  Y. Taniguchi,et al.  Genetic dissection of vertebrate 53BP1: a major role in non-homologous end joining of DNA double strand breaks. , 2006, DNA repair.

[21]  B. Demple,et al.  A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells. , 2005, Molecular cell.

[22]  R. Dumitrescu,et al.  Understanding breast cancer risk ‐ where do we stand in 2005? , 2005, Journal of cellular and molecular medicine.

[23]  N. Onishi,et al.  Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase , 2006, Cell Death and Differentiation.

[24]  S. McKinney-Freeman,et al.  Isolation and characterization of side population cells. , 2005, Methods in molecular biology.

[25]  L. Klein-Hitpass,et al.  Stringent Regulation of DNA Repair During Human Hematopoietic Differentiation: A Gene Expression and Functional Analysis , 2006, Stem cells.

[26]  Majlinda Lako,et al.  Stress Defense in Murine Embryonic Stem Cells Is Superior to That of Various Differentiated Murine Cells , 2004, Stem cells.

[27]  F. Alt,et al.  Control of sister chromatid recombination by histone H2AX. , 2004, Molecular cell.

[28]  Ralf Hass,et al.  Cellular responses to reactive oxygen species-induced DNA damage and aging , 2008, Biological chemistry.

[29]  Miao-Fen Chen,et al.  The sensitivity of human mesenchymal stem cells to ionizing radiation. , 2006, International journal of radiation oncology, biology, physics.

[30]  K. Riabowol,et al.  Grow-ING, Age-ING and Die-ING: ING proteins link cancer, senescence and apoptosis. , 2006, Experimental cell research.

[31]  Mary Anne Wheeler,et al.  Stem , 1985 .

[32]  A. Piga,et al.  Topoisomerase IIalpha and APE/ref-1 are associated with pathologic response to primary anthracycline-based chemotherapy for breast cancer. , 2005, Cancer letters.

[33]  D. Crowe,et al.  Tumor initiating cancer stem cells from human breast cancer cell lines. , 2009, International journal of oncology.

[34]  C. Rock,et al.  Diet and Biomarkers of Oxidative Damage in Women Previously Treated for Breast Cancer , 2005, Nutrition and cancer.

[35]  L. Elmore,et al.  Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction* , 2002, The Journal of Biological Chemistry.

[36]  F. Bertucci,et al.  Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. , 2009, Cancer research.

[37]  R. Bonner,et al.  Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks , 2003, Nature Cell Biology.

[38]  N. Mailand,et al.  The ATM–Chk2–Cdc25A checkpoint pathway guards against radioresistant DNA synthesis , 2001, Nature.

[39]  C. Prives,et al.  The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells , 2002, Oncogene.

[40]  Susan G Hilsenbeck,et al.  Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. , 2008, Journal of the National Cancer Institute.

[41]  Danila Coradini,et al.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. , 2005, Cancer research.

[42]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[43]  P. Stambrook,et al.  Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Chan,et al.  Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line , 1995, Science.

[45]  M. Clarke,et al.  Stem Cells and Cancer: Two Faces of Eve , 2006, Cell.

[46]  C. Stevens,et al.  Chk2 activates E2F-1 in response to DNA damage , 2003, Nature Cell Biology.

[47]  J. Nickoloff,et al.  Regulation of DNA double-strand break repair pathway choice , 2008, Cell Research.

[48]  M. Weinfeld,et al.  Stable down-regulation of human polynucleotide kinase enhances spontaneous mutation frequency and sensitizes cells to genotoxic agents. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[49]  E. Hiyama,et al.  Telomere and telomerase in stem cells , 2007, British Journal of Cancer.

[50]  I. Tsougos,et al.  Correlation between radiation-induced telomerase activity and human telomerase reverse transcriptase mRNA expression in HeLa cells , 2006, International journal of radiation biology.

[51]  David J. Chen,et al.  Two essential but distinct functions of the mammalian abasic endonuclease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[52]  L. Bracco,et al.  The requirement for the p53 proline‐rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression , 1998, The EMBO journal.

[53]  Y. Pommier,et al.  Phosphorylation of Histone H2AX and Activation of Mre11, Rad50, and Nbs1 in Response to Replication-dependent DNA Double-strand Breaks Induced by Mammalian DNA Topoisomerase I Cleavage Complexes* , 2003, Journal of Biological Chemistry.

[54]  Michael F. Clarke,et al.  Applying the principles of stem-cell biology to cancer , 2003, Nature Reviews Cancer.

[55]  L. Jardine.  Identification of senescence in cancer cells. , 2004, Methods in molecular medicine.

[56]  M. Mayberg,et al.  Induction of a Senescence-Like Phenotype in Bovine Aortic Endothelial Cells by Ionizing Radiation , 2001, Radiation research.

[57]  Hong Zhang.  Molecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging , 2007, Journal of cellular physiology.

[58]  M. Barbacid,et al.  Tumour biology: Senescence in premalignant tumours , 2005, Nature.

[59]  A. Piga,et al.  Topoisomerase IIα and APE/ref-1 are associated with pathologic response to primary anthracycline-based chemotherapy for breast cancer , 2005 .

[60]  Frank Pajonk,et al.  The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. , 2006, Journal of the National Cancer Institute.

[61]  G. Dianov,et al.  APE1 is the major 3'-phosphoglycolate activity in human cell extracts. , 2004, Nucleic acids research.